Do you want to read an article? Please log in or register.
Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review
Asthma
RECOMMENDED
Related content
RECOMMENDED
Asthma
Matching-Adjusted Indirect Comparison of Benralizumab versus Interleukin-5 Inhibitors: Systematic Review
Eur Respir J.
Bourdin A, Husereau D, Molinari N, Golam S, Siddiqui MK, Lindner L, Xu X
doi: 10.1183/13993003.
RECOMMENDED
Asthma
Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison
J Allergy Clin Immunol.
Busse W, Chupp G, Nagase H, Albers FC, Doyle S, Shen Q, Bratton DJ, Gunsoy NB
doi: 10.1016/j.jaci.2018.08.031.
Asthma
Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis
J Allergy Clin Immunol Pract.
Casale TB, Pacou M, Mesana L, Farge G, Sun SX, Castro M
doi: 10.1016/j.jaip.2018.08.036.
Asthma
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy
Drug Des Devel Ther.
Pelaia C, Vatrella A, Bruni A, Terracciano R, Pelaia G
doi: 10.2147/DDDT.S155307.
Asthma
The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review
Respir Res.
Matucci A, Vultaggio A, Danesi R
doi: 10.1186/s12931-018-0859-z.
RECOMMENDED
Lung Cancer
Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/-bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Halmos B, Burke T, Kalyvas C, Vandormael K, Frederickson A, Piperdi B
doi: 10.1016/j.lungcan.2021.03.020
Asthma
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
Lancet.
FitzGerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S, Gilmartin G, Werkström V, Aurivillius M, Goldman M; CALIMA study investigators
doi: 10.1016/
RECOMMENDED
Asthma
Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol
Respir Med.
von Bülow A, Backer V, Bodtger U, Søes-Petersen NU, Vest S, Steffensen I, Porsbjerg C
doi: 10.1016/j.rmed.2018.10.020.
Asthma
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
Drug Des Devel Ther.
Pelaia C, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Savino R, Pelaia G
doi: 10.2147/